379
Views
4
CrossRef citations to date
0
Altmetric
Review

Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients

ORCID Icon, , , , , , ORCID Icon, , & ORCID Icon show all
Pages 1435-1454 | Received 21 Jan 2021, Accepted 30 Jun 2021, Published online: 26 Jul 2021

References

  • Castro GA, Oliveira CA, Mahecha GA, et al. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res. 2011;303(7):513–520.
  • Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25.
  • Ramezanli T, Michniak-Kohn BB. Development and characterization of a topical gel formulation of adapalene-tyrospheres and assessment of its clinical efficacy. Mol Pharm. 2018;15(9):3813–3822.
  • Raza K, Singh B, Singla S, et al. Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling. Mol Pharm. 2013;10(5):1958–1963.
  • Karlapudi AP, Kodali VP, Kota KP, et al. Deciphering the effect of novel bacterial exopolysaccharide-based nanoparticle cream against Propionibacterium acnes. 3 Biotech. 2016;6(1):35.
  • Tan AU, Schlosser BJ, Paller AS. A review of diagnosis and treatment of acne in adult female patients. Int J Womens Dermatol. 2018;4(2):56–71.
  • Kim HJ, Lee B-J, Kwon A-R. The grease trap: uncovering the mechanism of the hydrophobic lid in Cutibacterium acnes lipase. J Lipid Res. 2020;61(5):722–733.
  • Dréno B, Pécastaings S, Corvec S, et al. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32(2):5–14.
  • Patel R, Prabhu P. Nanocarriers as versatile delivery systems for effective management of acne. Int J Pharm. 2020;579:119140.
  • Jain AK, Jain A, Garg NK, et al. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf B Biointerfaces. 2014;121:222–229.
  • Kahraman E, Güngör S, Özsoy Y. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Ther Deliv. 2017;8(11):967–985.
  • Sabouri M, Samadi A, Nasrollahi SA, et al. Tretinoin loaded nanoemulsion for acne vulgaris: fabrication, physicochemical and clinical efficacy assessments. Skin Pharmacol Physiol. 2018;31(6):316–323.
  • Silva EL, Carneiro G, Araujo LA, et al. Solid lipid nanoparticles loaded with retinoic acid and lauric acid as an alternative for topical treatment of acne vulgaris. J Nanosci Nanotechnol. 2015;15(1):792–799.
  • Jain A, Garg NK, Jain A, et al. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne. Drug Dev Ind Pharm. 2016;42(6):897–905.
  • Kumar B, Jalodia K, Kumar P, et al. Recent advances in nanoparticle-mediated drug delivery. J Drug Delivery Sci Technol. 2017;41:260–268.
  • Garg T. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 2016;44(1):98–105.
  • Pokharkar VB, Mendiratta C, Kyadarkunte AY, et al. Skin delivery aspects of benzoyl peroxide-loaded solid lipid nanoparticles for acne treatment. Ther Deliv. 2014;5(6):635–652.
  • Verma S, Utreja P, Kumar L. Nanotechnological Carriers for Treatment of Acne. Recent Pat Antiinfect Drug Discov. 2018;13(2):105–126.
  • Sathishkumar P, Preethi J, Vijayan R, et al. Anti-acne, anti-dandruff and anti-breast cancer efficacy of green synthesised silver nanoparticles using Coriandrum sativum leaf extract. J Photochem Photobiol B. 2016;163:69–76.
  • Layton AM. A review on the treatment of acne vulgaris. Int J Clin Pract. 2006;60(1):64–72.
  • Wosicka-Frąckowiak H, Cal K, Stefanowska J, et al. Roxithromycin-loaded lipid nanoparticles for follicular targeting. Int J Pharm. 2015;495(2):807–815.
  • Lapteva M, Möller M, Gurny R, et al. Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle. Nanoscale. 2015;7(44):18651–18662.
  • Główka E, Wosicka-Frąckowiak H, Hyla K, et al. Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles. Eur J Pharm Biopharm. 2014;88(1):75–84.
  • Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285–308.
  • Carter P, Narasimhan B, Wang Q. Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases. Int J Pharm. 2019;555:49–62.
  • Badilli U, Gumustas M, Uslu B, et al. Lipid-based nanoparticles for dermal drug delivery. In: Grumezescu AM, editor. Organic materials as smart nanocarriers for drug delivery. pp. 369–413: Elsevier Inc; 2018.
  • Amer SS, Nasr M, Mamdouh W, et al., Insights on the use of nanocarriers for acne alleviation. Curr Drug Deliv. 2019;16(1): 18–25.
  • Vanic Z, Holaeter A-M S-BN, Skalko-Basnet N. (Phospho)lipid-based nanosystems for skin administration. Curr Pharm Des. 2015;21(29):4174–4192.
  • Sala M, Diab R, Elaissari A, et al., Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm. 2018;535(1–2):1–17.
  • Ridolfi DM, Marcato PD, Justo GZ, et al. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces. 2012;93:36–40.
  • Vijayan V, Aafreen S, Sakthivel S, et al. Formulation and characterization of solid lipid nanoparticles loaded Neem oil for topical treatment of acne. J Acute Dis. 2013;2(4):282–286.
  • Raza K, Singh B, Singal P, et al. Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces. 2013;105:67–74.
  • Harde H, Agrawal AK, Katariya M, et al. Development of a topical adapalene-solid lipid nanoparticle loaded gel with enhanced efficacy and improved skin tolerability. RSC Adv. 2015;5(55):43917–43929.
  • Deshkar SS, Bhalerao SG, Jadhav MS, et al. Formulation and optimization of topical solid lipid nanoparticles based gel of dapsone using design of experiment. Pharm Nanotechnol. 2018;6(4):264–275.
  • Lin C-H, Fang Y-P, Al-Suwayeh SA, et al. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment. Biol Pharm Bull. 2013;36(2):276–286.
  • Prabhu P, Patravale V. The upcoming field of theranostic nanomedicine: an overview. J Biomed Nanotechnol. 2012;8(6):859–882.
  • Latter G, Grice JE, Mohammed Y, et al. Targeted topical delivery of retinoids in the management of acne vulgaris: current formulations and novel delivery systems. Pharmaceutics. 2019;11(10):490.
  • Raza K, Singh B, Lohan S, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm. 2013;456(1):65–72.
  • Elmowafy M, Shalaby K, Ali HM, et al. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies. Int J Pharm. 2019;572:118781.
  • Ghasemiyeh P, Azadi A, Daneshamouz S, et al. Cyproterone acetate-loaded nanostructured lipid carriers: effect of particle size on skin penetration and follicular targeting. Pharm Dev Technol. 2019;24(7):812–823.
  • Fatima N, Rehman S, Nabi B, et al. Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. J Drug Delivery Sci Technol. 2019;54:101253.
  • Lacatusu I, Istrati D, Bordei N, et al. Synergism of plant extract and vegetable oils-based lipid nanocarriers: emerging trends in development of advanced cosmetic prototype products. Mater Sci Eng C. 2020;108:110412.
  • Md S, Haque S, Madheswaran T, et al. Lipid based nanocarriers system for topical delivery of photosensitizers. Drug Discov Today. 2017;22(8):1274–1283.
  • Borges VR, Simon A, Sena AR, et al. Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation. Int J Nanomedicine. 2013;8:535–544.
  • Miastkowska M, Sikora E, Ogonowski J, et al. The kinetic study of isotretinoin release from nanoemulsion. Colloids Surf A Physicochem Eng Asp. 2016;510:63–68.
  • Najafi-Taher R, Ghaemi B, Amani A. Delivery of adapalene using a novel topical gel based on tea tree oil nano-emulsion: permeation, antibacterial and safety assessments. Eur J Pharm Sci. 2018;120:142–151.
  • Bhavsar B, Choksi B, Sanmukhani J, et al. Clindamycin 1% nano-emulsion gel formulation for the treatment of acne vulgaris: results of a randomized, active controlled, multicentre, Phase IV clinical trial. J Clin Diagn Res. 2014;8:YC05–YC09.
  • Najafi-Taher R, Amani A. Nanoemulsions: colloidal topical delivery systems for antiacne agents-A mini review. Nanomedicine. 2017;2:49–56.
  • Raminelli ACP, Romero V, Semreen MH, et al. Nanotechnological advances for cutaneous release of tretinoin: an approach to minimize side effects and improve therapeutic efficacy. Curr Med Chem. 2018;25(31):3703–3718.
  • Rahman SA, Abdelmalak NS, Badawi A, et al. Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients. Drug Deliv. 2016;23(4):1184–1193.
  • Hasanpouri A, Lotfipour F, Ghanbarzadeh S, et al. Improvement of dermal delivery of tetracycline using vesicular nanostructures. Res Pharm Sci. 2018;13(5):385–393.
  • Farkuh L, Hennies PT, Nunes C, et al. Characterization of phospholipid vesicles containing lauric acid: physicochemical basis for process and product development. Heliyon. 2019;5(10):e02648.
  • Kaur N, Puri R, Jain SK. Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent. AAPS PharmSciTech. 2010;11(2):528–537.
  • Sibinovska N, Komoni V, Netkovska KA, et al. Novel approaches in treatment of Acne vulgaris: patents related to micro/nanoparticulated carrier systems. Maced. Pharm. Bull. 2016;62(2):3–16.
  • Vyas A, Kumar Sonker A, Gidwani B. Carrier-based drug delivery system for treatment of acne. Scientific World J. 2014;2014:ID276260.
  • Vyas J, Puja V, Sawant K. Formulation and evaluation of topical niosomal gel of Erythromycin. Int J Pharm Pharm Sci. 2011;3(1):123–126.
  • Liu CH, Huang HY. In vitro anti-propionibacterium activity by curcumin containing vesicle system. Chem Pharm Bull. 2013;61(4):419–425.
  • Vyas J, Vyas P, Raval D, et al. Development of topical niosomal gel of benzoyl peroxide. ISRN Nanotechnol. 2011;2011:ID503158.
  • Dubey A, Prabhu P, Kabrawala H, et al. Niosomal gel of Adapalene: its formulation, physicochemical properties and evaluation for mild-acne. Adv Biomed Pharma. 2015;2(1):22–31.
  • Hatem AS, Fatma MM, Amal KH, et al. Dapsone in topical niosomes for treatment of acne vulgaris. African J. Pharm. Pharmacol. 2018;12(18):221–230.
  • Yu Z, Lv H, Han G, et al. Ethosomes Loaded with Cryptotanshinone for acne treatment through topical gel formulation. PLoS One. 2016;11(7):e0159967.
  • Kausar H, Mujeeba M, Ahadc A, et al. Optimization of ethosomes for topical thymoquinone delivery for the treatment of skin acne. J Drug Delivery Sci Technol. 2019;49:177–187.
  • Reddy Y, Sravani AB, Ravisankar V, et al. Transferosomes - a novel vesicular carrier for transdermal drug delivery system. J Innovations Pharm Biol Sci. 2015;2:193–208.
  • Khan S, Jain P, Jain S, et al. Topical delivery of erythromycin through cubosomes for acne. Pharm Nanotechnol. 2018;6(1):38–47.
  • Kwon T, Hong S, Kim JC. In vitro skin permeation of cubosomes containing triclosan. J Ind Eng Chem. 2012;18(1):563–567.
  • Shruti S, Gaurav G, Mohit A, et al. Formulation, in-vitro and ex-vivo evaluation of tretinoin loaded cubosomal gel for the treatment of acne. Recent Pat Drug Deliv Formul. 2018;12(2):121–129.
  • Nithya R, Jerold P, Siram K. Cubosomes of dapsone enhanced permeation across the skin. J Drug Delivery Sci Technol. 2018;48:75–81.
  • Ramezanli T, Zhang Z, Michniak-Kohn BB. Development and characterization of polymeric nanoparticle-based formulation of adapalene for topical acne therapy. Nanomedicine. 2017;13(1):143–152.
  • Tolentino S, Pereira M, Cunha-Filho M, et al. Targeted clindamycin delivery to pilosebaceous units by chitosan or hyaluronic acid nanoparticles for improved topical treatment of acne vulgaris. Carbohydr Polym. 2021;253:117295.
  • Abd-Allah H, Abdel-Aziz R, Nasr M. Chitosan nanoparticles making their way to clinical practice: a feasibility study on their topical use for acne treatment. Int J Biol Macromol. 2020;156:262–270.
  • Zhang Z, Tsai PC, Ramezanli T, et al. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Rev. Nanomed. Nanobiotechnol. 2013;5(3):205–218.
  • Kahraman E, Ozhan G, Ozsoy Y, et al. Polymeric micellar nanocarriers of benzoyl peroxide as potential follicular targeting approach for acne treatment. Colloids Surf B Biointerfaces. 2016;146:692–699.
  • Patel GC, Yadav BK. Polymeric nanofibers for controlled drug delivery applications. In: Grumezescu AM, editor. Organic materials as smart nanocarriers for drug delivery. Oxford and Cambridge: William Andrew; 2018. p. 147–175. Chapter 4.
  • Khoshbakht S, Asghari-Sana F, Fathi-Azarbayjani A, et al. Fabrication and characterization of tretinoin-loaded nanofiber for topical skin delivery. Biomater Res. 2020;24(1):8.
  • Sangnim T, Limmatvapiratb S, Nunthanidb J, et al. Design and characterization of clindamycin-loaded nanofiber patches composed of polyvinyl alcohol and tamarind seed gum and fabricated by electrohydrodynamic atomization. Asian J Pharm Sci. 2018;13(5):450–458.
  • Kamble P, Sadarani B, Majumdar A, et al. Nanofiber based drug delivery systems for skin: a promising therapeutic approach. J Drug Delivery Sci Technol. 2017;41:124–133.
  • Anselmo AC, Mitragotri SA. A review of clinical translation of inorganic nanoparticles. AAPS J. 2015;17(5):1041–1054.
  • Marassi V, Roda B, Casolari S, et al. Hollow-fiber flow field-flow fractionation and multi-angle light scattering as a new analytical solution for quality control in pharmaceutical nanotechnology. Microchem J. 2018;136:149–156.
  • Gupta A, Bonde SR, Gaikwad S, et al. Lawsonia inermis-mediated synthesis of silver nanoparticles: activity against human pathogenic fungi and bacteria with special reference to formulation of an antimicrobial nanogel. IET Nanobiotechnol. 2014;8(3):172–178.
  • Velmurugan P, Park JH, Lee SM, et al. Synthesis and characterization of nanosilver with antibacterial properties using Pinus densiflora young cone extract. J Photochem Photobiol B. 2015;147:63–68.
  • Jha D, Thiruveedula PK, Pathak R, et al. Multifunctional biosynthesized silver nanoparticles exhibiting excellent antimicrobial potential against multi-drug resistant microbes along with remarkable anticancerous properties. Mater Sci Eng C Mater Biol Appl. 2017;80:659–669.
  • Lee J-H, Velmurugan P, Park J-H, et al. A novel photo-biological engineering method for Salvia miltiorrhiza -mediated fabrication of silver nanoparticles using LED lights sources and its effectiveness against Aedes aegypti mosquito larvae and microbial pathogens. Physiol Mol Plant Pathol. 2018;101:178–186.
  • Badnore AU, Sorde KI, Datir KA, et al. Preparation of antibacterial peel-off facial mask formulation incorporating biosynthesized silver nanoparticles. Appl Nanosci. 2018;9(2):279–287.
  • Mahmoud N, Alkilany A, Khalil E, et al. Antibacterial activity of gold nanorods against Staphylococcus aureus and Propionibacterium acnes: misinterpretations and artifacts. Int J Nanomedicine. 2017;12:7311–7322.
  • Mahmoud NN, Hikmat S, Ghith DA, et al. Gold nanoparticles loaded into polymeric hydrogel for wound healing in rats: effect of nanoparticles’ shape and surface modification. Int J Pharm. 2019;565:174–186.
  • Mahmoud NN, Alkilany AM, Khalil EA, et al. Nano-photothermal ablation effect of hydrophilic and hydrophobic functionalized gold nanorods on Staphylococcus aureus and Propionibacterium acnes. Sci Rep. 2018;8(1):6881.
  • Crosera M, Prodi A, Mauro M, et al. Titanium dioxide nanoparticle penetration into the skin and effects on HaCaT cells. Int J Environ Res Public Health. 2015;12(8):9282–9297.
  • Wiesenthal A, Hunter L, Wang S, et al. Nanoparticles: small and mighty. Int J Dermatol. 2011;50(3):247–254.
  • Rajakumar G, Rahuman AA, Roopan SM, et al. Efficacy of larvicidal activity of green synthesized titanium dioxide nanoparticles using Mangifera indica extract against blood-feeding parasites. Parasitol Res. 2015;114(2):571–581.
  • Mahamuni-Badiger PP, Patil PM, Badiger MV, et al. Biofilm formation to inhibition: role of zinc oxide-based nanoparticles. Mater Sci Eng C. 2020;108:110319.
  • Stanić V, Tanasković SB. Nanotoxicity. 1st. Rajendran S, Mukherjee A, NguyenT, et al., editor. Chapter 11. Antibacterial activity of metal oxide nanoparticles, Amsterdam, Oxford and Cambridge: Elsevier. 2020. 241–274.
  • Lu PJ, Huang SC, Chen YP, et al. Analysis of titanium dioxide and zinc oxide nanoparticles in cosmetics. J Food Drug Anal. 2015;23(3):587–594.
  • Paithankar D, Hwang BH, Munavalli G, et al. Ultrasonic delivery of silica–gold nanoshells for photothermolysis of sebaceous glands in humans: nanotechnology from the bench to clinic. J Control Release. 2015;206:30–36.
  • Nafisi S, Schafer-Korting M, Maibach HI. Perspectives on percutaneous penetration: silica nanoparticles. Nanotoxicology. 2015;9(5):643–657.
  • Tomic I, Juretic M, Jug M, et al. Preparation of in situ hydrogels loaded with azelaic acid nanocrystals and their dermal application performance study. Int J Pharm. 2019;563:249–258.
  • Brammann C, Mueller-Goymann CC. Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: part I – nanocrystalline benzoyl peroxide. Int J Pharm. 2019;564:171–179.
  • Brammann C, Muller-Goymann CC. Incorporation of benzoyl peroxide nanocrystals into adapalene-loaded solid lipid microparticles: part II – solid-in-oil dispersion of nanoparticulate benzoyl peroxide. Int J Pharm. 2019;572:118792.
  • Mousavi SZ, Nafisi S, Maibach HI. Fullerene nanoparticle in dermatological and cosmetic applications. Nanomedicine. 2017;13(3):1071–1087.
  • Inui S, Aoshima H, Nishiyama A, et al. Improvement of acne vulgaris by topical fullerene application: unique impact on skin care. Nanomedicine. 2011;7(2):238–241.
  • Ascenso A, Guedes R, Bernardino R, et al. Complexation and Full Characterization of the Tretinoin and Dimethyl-βeta-Cyclodextrin Complex. AAPS PharmSciTech. 2011;12(2):553–563.
  • Borowska S, Brzoska MM. Metals in cosmetics: implications for human health. J Appl Toxicol. 2015;35(6):551–572.
  • Tucci P, Porta G, Agostini M, et al. Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes. Cell Death Dis. 2013;4(3):e549.
  • Hackenberg S, Kleinsasser N. Dermal toxicity of ZnO nanoparticles: a worrying feature of sunscreen? Nanomedicine. 2012;7(4):461–463.
  • Chang J, Lee CW, Alsulimani HH, et al. Role of fatty acid composites in the toxicity of titanium dioxide nanoparticles used in cosmetic products. J Toxicol Sci. 2016;41(4):533–542.
  • Botta C, Labille J, Auffan M, et al. TiO2-based nanoparticles released in water from commercialized sunscreens in a life-cycle perspective: structures and quantities. Environ Pollut. 2011;159(6):1543–1550.
  • Ma H, Williams PL, Diamond SA. Ecotoxicity of manufactured ZnO nanoparticles – a review. Environ Pollut. 2013;172:76–85.
  • Asharani PV, Lianwu Y, Gong Z, et al. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology. 2011;5(1):43–54.
  • Stecova J, Mehnert W, Blaschke T, et al. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res. 2007;24(5):991–1000.
  • Hristozov D, Gottardo S, Semenzin E, et al. Frameworks and tools for risk assessment of manufactured nanomaterials. Environ Int. 2016;95:36–53.
  • Directive 2001/83/EC of the European Parliement and the Council of 6 November 2001; 2001. [Acessed in 2020 Apr 22]. Available in: https://ec.europa.eu/health//sites/health/files/files/eudralex/vol1/dir_2001_83_consol_2012/dir_2001_83_cons_2012_en.pdf?fbclid=IwAR0uNCCRlQQlrX9pswHr2738hmt4KVXb1wcbQO5JMLi4eqSHlsedjiVJAtM
  • Regulation (EC) No 1221/2009 of the European Parliement and the Council of 25 November 2009; 2009. [Acessed in 2020 Apr 22]. Available in: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L:2009:342:FULL&from=EN
  • Comission Recommendation of 18 October 2011; 2011. [Acessed in 2020 Apr 22]. Available in: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32011H0696&from=EN
  • Gupta S, Bansal R, Gupta S, et al., Nanocarriers and nanoparticles for skin care and dermatological treatments. Indian Dermatol Online J. 2013;4(4):267–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.